Low-Density Granulocytes Affect T-SPOT.TB Assay by Inhibiting the Production of Interferon-γ in T Cells via PD-L1/PD-1 Pathway

被引:8
作者
Rao, Jiayue [1 ]
Su, Rigu [1 ]
Peng, Yiping [2 ]
Guo, Yang [1 ]
Huang, Zikun [1 ]
Ye, Yutao [1 ]
Gao, Yujie [1 ]
Liu, Jun [1 ]
Zhang, Lu [1 ]
Luo, Qing [1 ]
Li, Junming [1 ]
机构
[1] Nanchang Univ, Dept Clin Lab, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[2] Jiangxi Chest Hosp, Dept TB, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
low-density granulocytes; T-SPOT; TB; programmed death ligand 1; tuberculosis; T cells; TUBERCULOSIS; EXPRESSION;
D O I
10.3389/fmicb.2020.622389
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background T-SPOT TB (T-SPOT) assay is widely used for detection of Mycobacterium tuberculosis infection that is based on the detection of M. tuberculosis-specific interferon-gamma-secreting T cells (ISCs) in peripheral blood mononuclear cells (PBMCs). Recently, high frequencies of low-density granulocytes (LDGs) were found in the PBMCs of tuberculosis patients. Whether these LDGs affect the detection of T-SPOT has not been investigated. The impact of LDGs on T-SPOT assay and related mechanism were investigated in this study. Methods The correlations between the frequencies of LDGs and the results of T-SPOT were analyzed. T-SPOT with LDG-removed PBMCs and PBMCs with exogenous addition of LDGs were performed. The possible mechanism was explored by detecting the levels of negative immune regulatory molecules on LDGs. The impact of programmed death ligand 1 (PD-L1) on T-SPOT was evaluated and confirmed by function blocking with neutralizing antibody. Results The positive rates of T-SPOT and ISCs in tuberculosis patients with low LDGs frequency (n = 22) were significantly higher than those with high LDGs frequency (n = 39). Removal or exogenous addition of LDGs significantly increased or decreased the ISCs and the positive rate of T-SPOT. The frequencies of interferon-gamma-producing T cells were negatively correlated with the frequencies of LDGs. The expression of PD-L1 was significantly elevated on LDGs. Pretreatment of LDGs with anti-PD-L1 antibody significantly counteracted the impact of LDGs on T-SPOT. Treatment of PBMCs with anti-PD-L1 antibody resulted in comparable ISCs with that of LDG removal. Conclusion LDGs can inhibit the production of interferon-gamma in T cells and decrease the positive rated of T-SPOT assay via highly expressed PD-L1.
引用
收藏
页数:10
相关论文
共 29 条
[11]   Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis [J].
Jurado, Javier O. ;
Alvarez, Ivana B. ;
Pasquinelli, Virginia ;
Martinez, Gustavo J. ;
Quiroga, Maria F. ;
Abbate, Eduardo ;
Musella, Rosa M. ;
Chuluyan, H. Eduardo ;
Garcia, Veronica E. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (01) :116-125
[12]   Mycobacterium tuberculosis Drives Expansion of Low-Density Neutrophils Equipped With Regulatory Activities [J].
La Manna, Marco Pio ;
Orlando, Valentina ;
Paraboschi, Elvezia Maria ;
Tamburini, Bartolo ;
Di Carlo, Paola ;
Cascio, Antonio ;
Asselta, Rosanna ;
Dieli, Francesco ;
Caccamo, Nadia .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[13]   Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets [J].
Lang, Stephan ;
Bruderek, Kirsten ;
Kaspar, Cordelia ;
Hoeing, Benedikt ;
Kanaan, Oliver ;
Dominas, Nina ;
Hussain, Timon ;
Droege, Freya ;
Eyth, Christian ;
Hadaschik, Boris ;
Brandau, Sven .
CLINICAL CANCER RESEARCH, 2018, 24 (19) :4834-4844
[14]   A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases [J].
Lee, Choon Kin ;
Wong, Sunny H. V. ;
Lui, Grace ;
Tang, Whitney ;
Tam, Lai San ;
Ip, Margaret ;
Hung, Esther ;
Chen, Minhu ;
Wu, Justin C. ;
Ng, Siew C. .
JOURNAL OF CROHNS & COLITIS, 2018, 12 (08) :954-962
[15]   Quantitative investigation of factors relevant to the T cell spot test for tuberculosis infection in active tuberculosis [J].
Li, Kui ;
Yang, Caiyong ;
Jiang, Zicheng ;
Liu, Shengxi ;
Liu, Jun ;
Fan, Chuanqi ;
Li, Tao ;
Dong, Xuemin .
BMC INFECTIOUS DISEASES, 2019, 19 (1)
[16]   The interplay between tuberculosis and systemic lupus erythematosus [J].
Moreira Balbi, Gustavo Guimaraes ;
Machado-Ribeiro, Francinne ;
Marques, Claudia D. L. ;
Signorelli, Flavio ;
Levy, Roger Abramino .
CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (04) :395-402
[17]   Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells [J].
Moses, Katrin ;
Brandau, Sven .
SEMINARS IN IMMUNOLOGY, 2016, 28 (02) :187-196
[18]   Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015 [J].
Nguyen, Duc T. ;
Teeter, Larry D. ;
Graves, Julie ;
Graviss, Edward A. .
EMERGING INFECTIOUS DISEASES, 2018, 24 (03) :534-540
[19]   Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus [J].
Rahman, Saifur ;
Sagar, Divya ;
Hanna, Richard N. ;
Lightfoot, Yaima L. ;
Mistry, Pragnesh ;
Smith, Carolyne K. ;
Manna, Zerai ;
Hasni, Sarfaraz ;
Siegel, Richard M. ;
Sanjuan, Miguel A. ;
Kolbeck, Roland ;
Kaplan, Mariana J. ;
Casey, Kerry A. .
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (07) :957-966
[20]   Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer [J].
Sagiv, Jitka Y. ;
Michaeli, Janna ;
Assi, Simaan ;
Mishalian, Inbal ;
Kisos, Hen ;
Levy, Liran ;
Damti, Pazzit ;
Lumbroso, Delphine ;
Polyansky, Lola ;
Sionov, Ronit V. ;
Ariel, Amiram ;
Hovav, Avi-Hai ;
Henke, Erik ;
Fridlender, Zvi G. ;
Granot, Zvi .
CELL REPORTS, 2015, 10 (04) :562-573